Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)

Korea Arlico Pharm Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	13,055	15,484	19,066	23,395	9,520	5,506
Short-Term Investments	666.87	652.72	6,164	6,512	13,612	10,544
Trading Asset Securities	1,079	3,057	5,560	2,296	5,616	3,466
Cash & Short-Term Investments	14,802	19,194	30,790	32,203	28,747	19,516
Cash Growth	-41.68%	-37.66%	-4.39%	12.02%	47.30%	-47.50%
Accounts Receivable	27,581	30,073	22,362	19,886	19,304	19,207
Other Receivables	765.91	50.12	46.58	110.46	74.88	151.41
Receivables	28,347	30,123	22,409	19,997	19,379	19,359
Inventory	36,632	32,798	26,779	27,437	19,759	18,918
Prepaid Expenses	-	7.05	7.97	7.25	5.78	7.23
Other Current Assets	4,950	3,212	3,570	2,479	964.07	184.17
Total Current Assets	84,730	85,334	83,555	82,123	68,855	57,984
Property, Plant & Equipment	63,105	63,152	66,740	49,726	31,641	26,661
Long-Term Investments	8,135	8,730	10,137	9,313	12,168	9,367
Other Intangible Assets	7,526	7,148	7,013	6,958	3,967	4,402
Long-Term Accounts Receivable	-	-	-0	0	0	0
Long-Term Deferred Tax Assets	6,140	6,140	4,365	4,071	3,741	2,834
Other Long-Term Assets	882.16	859.02	1,666	1,344	688.89	9,040
Total Assets	171,518	172,363	173,477	153,536	121,062	110,288
Accounts Payable	8,405	7,325	4,851	4,806	5,111	3,365
Accrued Expenses	9,114	10,699	11,868	12,407	10,038	342
Short-Term Debt	39,923	41,537	39,330	25,064	10,262	4,220
Current Portion of Long-Term Debt	2,167	1,932	-	2,000	191.4	3,216
Current Portion of Leases	234.64	250.58	152.42	151.35	82.2	41.57
Current Income Taxes Payable	-	-	-	883.22	840.4	982.53
Current Unearned Revenue	-	-	-	2.46	-	-
Other Current Liabilities	14,457	13,452	14,119	11,944	7,244	14,812
Total Current Liabilities	74,300	75,195	70,320	57,258	33,770	26,980
Long-Term Debt	6,944	6,592	6,746	3,746	2,000	2,191
Long-Term Leases	145.31	145.65	61.2	135.05	65.21	33.16
Other Long-Term Liabilities	10,100	10,140	7,275	3,851	3,370	3,270
Total Liabilities	92,509	92,684	84,402	64,990	39,933	32,721
Common Stock	7,664	7,664	7,664	7,664	7,664	4,911
Additional Paid-In Capital	40,143	40,143	40,143	40,143	40,143	42,919
Retained Earnings	34,850	35,520	43,743	43,156	35,904	31,983
Treasury Stock	-3,082	-3,082	-3,082	-3,082	-3,082	-2,536
Comprehensive Income & Other	-565.06	-565.06	608.09	665.54	501.14	290.23
Shareholders' Equity	79,009	79,679	89,075	88,546	81,129	77,566
Total Liabilities & Equity	171,518	172,363	173,477	153,536	121,062	110,288
Total Debt	49,414	50,457	46,289	31,096	12,601	9,702
Net Cash (Debt)	-34,612	-31,263	-15,499	1,107	16,146	9,814
Net Cash Growth	-	-	-	-93.14%	64.53%	-20.89%
Net Cash Per Share	-2313.75	-2082.32	-526.62	73.29	1071.03	650.58
Filing Date Shares Outstanding	14.78	15.01	15.01	15.01	15.01	14.36
Total Common Shares Outstanding	14.78	15.01	15.01	15.01	15.01	14.36
Working Capital	10,430	10,139	13,235	24,865	35,085	31,004
Book Value Per Share	5346.53	5307.22	5933.04	5897.81	5403.78	5400.05
Tangible Book Value	71,484	72,531	82,062	81,588	77,162	73,164
Tangible Book Value Per Share	4837.26	4831.12	5465.90	5434.34	5139.54	5093.59
Land	10,884	10,884	11,406	10,188	9,607	7,151
Buildings	24,855	25,046	30,181	12,824	15,655	14,011
Machinery	14,136	15,334	31,527	8,822	15,961	14,075
Construction In Progress	11,167	9,767	10,784	16,418	1,608	584.85

Source: S&P Global Market Intelligence. Standard template. Financial Sources.